Takeaways From FTC's Challenge Of Amgen Deal
By Matthew Perlman · May 18, 2023, 7:25 PM EDT
The Federal Trade Commission's move this week to block Amgen Inc.'s proposed $27.8 billion purchase of Horizon Therapeutics PLC shows an aggressive attack by enforcers on a transaction that may not...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login